An Interview With the Food and Drug Administration About Draft Patient-Focused Drug Development Guidance 3: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments

Value Health. 2023 Jun;26(6):791-795. doi: 10.1016/j.jval.2023.04.006. Epub 2023 Apr 26.
No abstract available

Publication types

  • Interview
  • Editorial

MeSH terms

  • Data Collection
  • Drug Approval
  • Drug Development*
  • Humans
  • Outcome Assessment, Health Care*
  • United States
  • United States Food and Drug Administration